Table 3.
Best overall response | Doxorubicin ≧ 75 mg/m2 (n = 16), no. (%) | Doxorubicin < 75 mg/m2 (n = 22), no. (%) |
---|---|---|
Complete response | 0 (0) | 0 (0) |
Partial response | 2 (13) | 2 (6) |
Overall response | 2 (13) | 2 (6) |
Stable disease | 5 (31) | 14 (44) |
Progressive disease | 8 (50) | 6 (19) |
Not evaluable or not assessed | 1 (6) | 0 (0) |